Direct and indirect costs associated with the onset of seropositive rheumatoid arthritis. Western Consortium of Practicing Rheumatologists

scientific article published on May 2000

Direct and indirect costs associated with the onset of seropositive rheumatoid arthritis. Western Consortium of Practicing Rheumatologists is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID10813281

P2093author name stringLee M
Wong WK
Bulpitt KJ
Paulus HE
Park G
Clements P
Ramos B
Sterz M
Law NJ
Newhall-Perry K
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectrheumatoid arthritisQ187255
P304page(s)1156-1163
P577publication date2000-05-01
P1433published inThe Journal of RheumatologyQ7743623
P1476titleDirect and indirect costs associated with the onset of seropositive rheumatoid arthritis. Western Consortium of Practicing Rheumatologists
P478volume27

Reverse relations

cites work (P2860)
Q34398912A review of the direct costs of rheumatoid arthritis: managed care versus fee-for-service settings
Q92188732Analysis of the Indirect Costs of Rheumatoid Arthritis in Romania
Q26798332Burden of illness of rheumatoid arthritis in Latin America: a regional perspective
Q33717053Cost-effectiveness of adding magnetic resonance imaging to rheumatoid arthritis management.
Q36581690Cost-of-illness studies : a review of current methods.
Q35552992Direct costs of ankylosing spondylitis and its determinants: an analysis among three European countries
Q35780338Epidemiology and burden of illness of rheumatoid arthritis
Q36100671International variation in resource utilisation and treatment costs for rheumatoid arthritis: a systematic literature review
Q31019080Monetary value of lost productivity over a five year follow up in early rheumatoid arthritis estimated on the basis of official register data on patients' sickness absence and gross income: experience from the FIN-RACo trial.
Q37021279Openness to and preference for attributes of biologic therapy prior to initiation among patients with rheumatoid arthritis: patient and rheumatologist perspectives and implications for decision making
Q35555089Productivity costs among patients with rheumatoid arthritis: the influence of methods and sources to value loss of productivity
Q36166120Sick leave and work disability in patients with early arthritis
Q81478994The case for stratified cost-effectiveness analysis by baseline health-related QOL: theory and sensitivity analysis
Q36985736Work disability in scleroderma is greater than in rheumatoid arthritis and is predicted by high HAQ scores.
Q35551561Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries.
Q37707491Workability and Muscle Strength in Patients With Seropositive Rheumatoid Arthritis: Survey Study Protocol.
Q50480670[Productivity costs of rheumatoid arthritis in Germany. Cost composition and prediction of main cost components].

Search more.